Supernus Pharmaceuticals, Inc. (SUPN) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to Sopernos Pharmaceuticals' first quarter 2026 financial results conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session. Instructions will follow at that time. As a reminder, this conference is being recorded. I would now like to turn the conference over to Peter Vazzo of ICR Healthcare, Investor Relations Representative for Sopernis Pharmaceuticals. You may begin. Thank you. Good afternoon, everyone, and thank you for joining us today for Sopernis Pharmaceuticals' first quarter 2026 financial results conference call. Today, after the close of the market, the company issued a press release announcing these results. On the call with me today are Sopernis' Chief Executive Officer, Jack Picar, and Chief Financial Officer, Tim Dannen. Today's call is being made available via the investor relations section of the company's website at www.ir.sopernis.com. During the course of this call, management may make certain forward-looking statements regarding future events and the company's future performance. These forward-looking statements reflect Sopernis' current perspective on existing trends and information. Any such forward-looking statements are not guaranteed of future performance and involve risks and uncertainty. including those noted in the risk factor section of the company's latest SEC filing. Actual results may differ materially from those projected in these forward-looking statements. For the benefit of those of you who may be listening to the replay, this call is being held and recorded on May 5th, 2026. Since then, the company may have made additional announcements relating to the topics discussed. Please reference the company's most recent press releases and cur...